Character | Response | |
---|---|---|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
McLaughlin, S. D., Walker, A. W., Churcher, C., Clark, S. K., Tekkis, P. P., Johnson, M. W., Parkhill, J., Ciclitira, P. J., Dougan, G., Nicholls, R. J., & Petrovska, L. (2010). The bacteriology of pouchitis: a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencing. Annals of Surgery, 252(1), 90–98.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces, and rat mouth
DNA G+C(%): 41-43
|
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
Augmentin: S(MIC50): 0.25, MIC90: 2, RNG: (0.06-4)
penicillin_G: Var(MIC50): 1, MIC90: 8, RNG: (0.06-8)
|
cefalexin: Var(MIC50): 2, MIC90: 8, RNG: (0.25-16)
|
kanamycin: S(1000; disc)
|
azithromycin: S(MIC50): 1, MIC90: 2, RNG: (0.125->32)
erythromycin: Var(MIC50): 4, MIC90: 8, RNG: (0.5->32)
|
ciprofloxacin: S(MIC50): ≤0.5, MIC90: 4, RNG: (≤0.5->8)
levofloxacin: S(MIC50): 0.25, MIC90: 0.5, RNG: (≤0.06-8)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
tetracycline: Var(MIC50): 2, MIC90: 16, RNG: (0.5-32)
|
vancomycin: R(5; disc)
|
|
metronidazole: S(MIC50): 2, MIC90: 4, RNG: (0.125-4)
|
clindamycin: S(MIC50): 0.06, MIC90: 0.125, RNG: (≤0.03->32)
colistin: R(10; disc)
|